EIC
SNY icon

Equity Investment Corp’s Sanofi SNY Stock Holding History

Equity Investment Corp’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Sell
2,601,971
-61,083
-2% -$2.73M 2.12% 23
2026
Q1 		$128M Buy
2,663,054
+38,842
+1% +$1.81M 2.51% 15
2025
Q4 		$127M Buy
2,624,212
+36,522
+1% +$1.81M 2.57% 10
2025
Q3 		$122M Buy
2,587,690
+75,255
+3% +$3.63M 2.56% 12
2025
Q2 		$121M Buy
2,512,435
+62,109
+3% +$3.17M 2.66% 12
2025
Q1 		$136M Buy
2,450,326
+44,137
+2% +$2.39M 3.04% 7
2024
Q4 		$116M Sell
2,406,189
-52,395
-2% -$2.66M 2.72% 11
2024
Q3 		$142M Sell
2,458,584
-2,610
-0.1% -$141K 3.3% 8
2024
Q2 		$119M Buy
2,461,194
+67,720
+3% +$3.27M 3.05% 9
2024
Q1 		$116M Buy
2,393,474
+447,872
+23% +$21.9M 2.91% 11
2023
Q4 		$96.8M Sell
1,945,602
-6,743
-0.3% -$330K 2.72% 15
2023
Q3 		$105M Buy
1,952,345
+4,191
+0.2% +$223K 3.26% 8
2023
Q2 		$105M Sell
1,948,154
-60,294
-3% -$3.24M 3.25% 7
2023
Q1 		$109M Buy
2,008,448
+81,015
+4% +$3.94M 3.58% 7
2022
Q4 		$93.3M Buy
1,927,433
+373,685
+24% +$16.4M 3.14% 9
2022
Q3 		$59.1M Sell
1,553,748
-138,881
-8% -$6.19M 2.27% 22
2022
Q2 		$84.7M Buy
1,692,629
+36,565
+2% +$1.94M 3.14% 10
2022
Q1 		$85M Buy
1,656,064
+206,079
+14% +$10.6M 2.9% 11
2021
Q4 		$72.6M Sell
1,449,985
-70,666
-5% -$3.5M 2.63% 16
2021
Q3 		$73.3M Sell
1,520,651
-11,158
-0.7% -$567K 2.81% 16
2021
Q2 		$80.7M Buy
1,531,809
+620,942
+68% +$32.4M 3.04% 8
2021
Q1 		$45.1M Buy
910,867
+17,490
+2% +$840K 1.79% 29
2020
Q4 		$43.4M Sell
893,377
-59,342
-6% -$2.93M 2.02% 29
2020
Q3 		$47.8M Sell
952,719
-58,994
-6% -$3.04M 2.43% 20
2020
Q2 		$51.6M Sell
1,011,713
-98,189
-9% -$4.77M 2.57% 17
2020
Q1 		$48.5M Sell
1,109,902
-175,759
-14% -$8.41M 2.5% 17
2019
Q4 		$64.5M Sell
1,285,661
-8,832
-0.7% -$414K 2.22% 23
2019
Q3 		$60M Buy
+1,294,493
New +$55.8M 2.14% 23

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Equity Investment Corp's SNY Position: Q2 2026 in Review

Equity Investment Corp reduced its Sanofi (SNY) stake by 2.3% in Q2 2026, selling an estimated $2.73M and leaving 2,601,971 shares worth $111M. The position accounts for 2.12% of the portfolio, ranked #23.

Equity Investment Corp first reported a position in SNY in Q3 2019 and has held it in 28 quarters since. The position peaked at $142M in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Equity Investment Corp held 2,601,971 shares of Sanofi worth $111M as of Q2 2026.
  • Equity Investment Corp sold 61,083 Sanofi shares in Q2 2026, an estimated $2.73M.
  • Sanofi made up 2.12% of Equity Investment Corp's portfolio in Q2 2026, its #23 holding.
  • Equity Investment Corp first reported a position in Sanofi in Q3 2019 and has held it in 28 quarters since.
  • Equity Investment Corp's Sanofi position peaked at $142M in Q3 2024.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Equity Investment Corp's 13F filing for Q2 2026, filed 7 Aug 2026.